
GUTS BV offers AI-powered, high-throughput in vitro modelling platforms for pharma and nutrition. These platforms enable predictive analytics and machine learning insights from experimental data. The core tech combines in vitro models with AI and data analytics to improve testing efficiency. The company targets pharmaceutical and nutritional industries and operates as a B2B platform. With scalable workflows and potential integration into existing R&D pipelines, GUTS BV aims to accelerate discovery and testing.

GUTS BV offers AI-powered, high-throughput in vitro modelling platforms for pharma and nutrition. These platforms enable predictive analytics and machine learning insights from experimental data. The core tech combines in vitro models with AI and data analytics to improve testing efficiency. The company targets pharmaceutical and nutritional industries and operates as a B2B platform. With scalable workflows and potential integration into existing R&D pipelines, GUTS BV aims to accelerate discovery and testing.